Transradial Application of PercuSurge GuardWire Device during Primary Percutaneous Intervention of Infarct-Related Artery with High-Burden Thrombus Formation

Catheterization and Cardiovascular Interventions

Volumn 61, Issue 4, 2004, Pages 503-511

  Yip, Hon Kan ^a   Chen, Mien Cheng ^a   Chang, Hsueh Wen ^b   Kuo, Fan Ying ^a   Yang, Cheng Hsu ^a   Chen, Shyh Ming ^a   Hung, Wei Chin ^a   Chen, Chien Jen ^a   Cheng, Cheng I ^a   Wu, Chiung Jen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Large infarct artery; Primary coronary intervention; Transradial application of PercuSurge GuardWire device

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEVICE; FEMALE; FEMORAL ARTERY; GUIDE WIRE; HEART INFARCTION; HUMAN; INFARCT RELATED ARTERY WITH HIGH BURDEN THROMBUS FORMATION; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; THROMBOEMBOLISM; THROMBOGENESIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; EQUIPMENT DESIGN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; TAIWAN; TREATMENT OUTCOME; TYROSINE;

EID: 12144290089     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10685     Document Type: Article

References (21)

1. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, Hartzler GO, Overlie P, Donohue B, Chelllah N, Timmis GC, Vlietstra R, Strzelecki M, Puchrowicz-Ochocki S, O'Neill W. Predictors of in-hospital and 6 month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995;25:370-377.
2. Brener SJ, Barr LA, Burchenal JEB, Katz S, George BS, Jones AA, Cohen ED, Gainey PC, White HJ, Cheek HB, Moses JW, Moliterno DJ, Effron MB, Topol EJ. Randomized, placebo-control trial of platelet glycoprotein IIb/IIa blockage with primary angioplasty for acute myocardial infarction. Circulation 1998;98:734-741.
3. Cura FA, L'Allier PL, Kapadia SR, Houghtaling PL, Dipaola LM, Ellis SG, Topol EJ, Brener SJ. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol 2001;88:124-128.
4. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansieri M, Choussat R, Pinton P. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-1903.
5. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966.
6. Yip HK, Wu CJ, Chang HW, Chen MC, Hang CL, Fang CY, Hsieh YK, Yang CH, Yeh KH, Fu M. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 2001;87:1184-1188.
7. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow. Chest 2002;122:1322-1332.
8. Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, Shimada K, Yoshikawa J. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002;105:2148-2152.
9. TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-936.
10. Carlino M, De Gregorio J, Di Mario C, Anzuini A, Airoldi F, Albiero R, Briguori C, Dharmadhikari A, Sheiban I, Colombo A. Prevention of distal embolization during saphenous vein graft lesion angioplasty: experience with new temporary occlusion and aspiration system. Circulation 1999;99:3221-3223.
11. Grube E, Gerckens U, Yeung AC, Rowold S, Kirchhof N, Sedgewick J, Yadav JS, Stertzer S. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001;104:2436-2441.
12. Bain DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KKL, Kuntz RE. A randomized trial of a distal embolic protection device during percutaneous intervention in saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290.
13. Belli G, Pezzano A, De Biase AM, Bonacina E, Silva P, Salvade P, Piccalo G, Klugmamn S. Adjunctive thrombus aspiration and mechanical protection from distal embolization in primary percutaneous intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2000;50:362-370.
14. Gibson CM, Cannon CP, Daley WL, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole K, Braunwald E. TIMI frame count: a quantitative method for assessing coronary artery flow. Circulation 1996;93:879-888.
15. Van't Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998;97:2302-2306.
16. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCable CH, Cannon P, Antman EM, Braunwald E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 2001;103:2550-2554.
17. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Kneefe J, Overlie P, Donohue B, Chelliah N, Timmis GG, Vlietstra RE, Strzelecki M, Puchrowicz-Ochocki S, O'Neill W. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679.
18. Lefkovits J, Ivanhoe RJ, Califf RM, Bergelson BA, Anderson KM, Stoner GL, Weisman HF, Topol EJ. Effect of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996;77:1045-1051.
19. Giri S, Mitchel JF, Hirst JA, McKay RG, Azar RR, Mennett R, Waters DD, Kiernan FJ. Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction. Am J Cardiol 2000;86:268-274.
20. Fujii T, Ueda M, Ikura Y, Osawa M, Kawano S, Ito H, Fujii K, Yoshiyama M, Tacheuchi K, Yashikawa J. Aspiration intracoronary thrombus by Rescue PT catheter: histological and immunohistochemical analyses. Circulation 2002;66(Suppl):I458.
21. Poli A, Fetiveau R, Vandoni P, del Rosso G, D'Urbano M, Seveso G, Cafiero F, De Servi S. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation 2002;106:313-318.